Prophylaxis of cytomegalovirus disease in high-risk patients.

被引：2
|
作者：
Scholz, M
Cinatl, J
Doerr, W
机构：
[1] Johann Wolfgang Goethe-Universität,Institut für Medizinische Virologie
来源：
INFECTION | 1997年 / 25卷 / 05期
关键词：
D O I：
10.1007/BF01720395
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
CMV disease is an important peristent factor for enhanced morbidity and mortality in immunocompromised patients. In high-risk patients the prevention of primary infection or reactivation of latent infection is endeavoured by means of various antiviral strategies. However, the prevention of CMV disease by immunomodulators appears to be a hopeful additional tool for the treatment of immunocompromised patients and ought to be further investigated.
引用
收藏
页码：269 / 273
页数：5
相关论文
共 50 条
  • [21] Effectiveness of Valganciclovir Cytomegalovirus Prophylaxis Protocol in High-Risk Liver Transplant Recipients
    Shivega, W. Gaya
    Samhan, Aya
    Bolognese, Alexandra
    Enestvedt, Kristian
    Maynard, Erin
    Orloff, Susan
    Scott, David
    Woodland, David
    Olyaei, Ali
    Connelly, Christopher
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S51 - S51
  • [22] GANCICLOVIR IN CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    PROKURAT, S
    DRABIK, E
    GRENDA, R
    VOGT, E
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (04) : 2577 - 2577
  • [23] Cytomegalovirus prophylaxis by passive immunization in high-risk kidney and heart transplant recipients
    Weimar, W
    Metselaar, HJ
    Balk, AHMM
    IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL II, PTS 1 AND 2, 1996, : 587 - 591
  • [24] Reaching High-Risk Patients for HIV Preexposure Prophylaxis
    Riddell, James
    Cohn, Jonathan A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (02): : 211 - +
  • [25] Amiodarone prophylaxis for atrial fibrillation of high-risk patients
    Budeus, M.
    Feindt, P.
    Gams, E.
    Reimert, K.
    Felix, O.
    Wieneke, H.
    Sack, S.
    Erbel, R.
    EUROPEAN HEART JOURNAL, 2006, 27 : 882 - 882
  • [26] Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients
    Kletzmayr, J
    Kotzmann, H
    PopowKraupp, T
    Kovarik, J
    Klauser, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (02): : 325 - 330
  • [27] Endocarditis Prophylaxis continues to be important in High-risk Patients
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2019, 8 (01) : 27 - +
  • [28] Cytomegalovirus events in high-risk allogeneic hematopoietic-cell transplantation patients who received letermovir prophylaxis
    Chen, Kaiwen
    Arbona-Haddad, Esther
    Cheng, Matthew P.
    McDonnell, Anne M.
    Gooptu, Mahasweta
    Orejas, Jose L.
    Timblin, Kaitlyn
    Silverman, Emily
    Al-Hamed, Rama
    Soiffer, Robert J.
    Hammond, Sarah P.
    Marty, Francisco M.
    TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [29] Fatal cytomegalovirus disease in a high-risk renal transplant recipient
    Frank Tenney
    Abdullah Sakarcan
    Pediatric Nephrology, 2001, 16 : 8 - 10
  • [30] Fatal cytomegalovirus disease in a high-risk renal transplant recipient
    Tenney, F
    Sakarcan, A
    PEDIATRIC NEPHROLOGY, 2001, 16 (01) : 8 - 10
12345